a year ago for its effort to “rip up the playbook on drug pricing,” may launch with Mark Cuban’s Cost Plus Drugs in a different role than originally billed.the prescription management model that also includes Amazon, a pharmacy benefit venture owned by Blue Cross and Blue Shield plansBlue Shield of California said Mark Cuban Cost Plus Drug Company will “establish a simple, transparent, and more affordable pricing model, reducing surprise drug costs at the pharmacy pick-up counter.
The entrepreneur Mark Cuban could not be reached Thursday for comment and Mark Cuban Cost Plus Drug Company executives declined to comment when reached Thursday. As more expensive specialty drugs from Alzheimer treatments to new drugs for cancer hit the U.S. market, those handling prescriptions and their claims are bracing for an even larger focus on these costly medicines.
Long gone are the days when health plans and PBMs had to worry about the launch of a new cholesterol pill or prescription antidepressant that would cost $4 each and be taken by millions of Americans. These days, it’s specialty drugs derived from biotechnology that may only be 1% to 2% of the claims health plans process for an employer or government client but are becoming a more dominant part of what they have to administer and manage.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: dcexaminer - 🏆 6. / 94 続きを読む »
ソース: FoxNews - 🏆 9. / 87 続きを読む »
ソース: clevelanddotcom - 🏆 301. / 63 続きを読む »